The treatment, now available in England, targets myeloma, a blood cancer affecting plasma cells in the bone marrow. It ...

Researchers at Johns Hopkins University have made a significant stride in early cancer detection. Their study reveals a blood ...

In a world increasingly turning to pharmaceuticals for weight loss and metabolic control, a quieter contender is re-entering ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

A Peter Mac-initiated clinical trial suggests a way to dramatically improve outcomes in patients with high-risk forms of ...

Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

Chief Executive James McLaughlin is lacing up his trainers once more for one final run, taking on his toughest test ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

The benefits of basic scientific study take time, even decades after an initial finding. Research cuts will hinder our ...

Leukaemia and lymphoma are among the most common forms of blood cancer and are often difficult to detect early and ...

Amplia Therapeutics has reported a 'complete response' from a patient with metastasised pancreatic cancer: "A rare event".

An mRNA-based diagnostic test is being developed that could catch cancers earlier, when they're more treatable. But this innovation is under threat.